anticancer peptide (Hexima)

N/A

Report date: 2025/01/26 18:03:56

Base Information

Drug Nameanticancer peptide (Hexima)
Drug Alias Namenon-melanoma skin cancer therapeutic (Acrux/Hexima)
ClassificationBiologics > Protein drugs > Recombinant polypeptideNatural product/Extract
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSkin Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAcrux
China Registration ClassN/A

Develop Information

Active CompaniesHexima
Inactive CompaniesAcrux
Active IndicationsSkin Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A